Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology 2023-08-01 19:00
Doer Biologics Announces First Subject Dosed in Phase I 12-Week Multiple-Ascending Dose (MAD) Clinical Trial of DR10624 and Received IND Approval From NMPA 2023-08-01 17:08
Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023 2023-08-01 01:00
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC 2023-08-01 00:00
Fosun Health Capital reached a cooperation agreement with Medicilon to explore innovative drug research and development together 2023-07-31 20:30
WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022 2023-07-31 18:02
111 to Announce Second Quarter 2023 Unaudited Financial Results on August 24, 2023 - Conference Call to Follow 2023-07-31 17:59
Biosion Announces Phase II Study Start for Anti-TSLP mAb BSI-045B in Atopic Dermatitis (ADAMANT) 2023-07-31 17:05
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME 2023-07-31 15:00
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
J INTS BIO, Novel Oral 4th Generation EGFR TKI 'JIN-A02' - Dosing of First Patient in the Global Multi-center Phase 1/2 Clinical Study began 2023-07-31 13:10
Akeso Inc. Published 2023 Interim Results Positive Profit Alert 2023-07-31 12:33
NMPA and FDA Approved the First-in-Human Clinical Trial Applications to Evaluate LBL-034, An Anti-GPRC5D/CD3 Bispecific Antibody Developed by Leads Biolabs, in Relapsed/Refractory Multiple Myeloma 2023-07-31 12:09
VARON Reiterates Its Commitment to Brand Value and Its Determination to Reshape the Oxygen Concentrator Industry 2023-07-28 22:20
HANQUYOU Marks 3rd Anniversary with Brilliant Achievements 2023-07-28 15:27
Wuan Ankang Hospital's Innovative Tumor Treatment Attracts Many Patients 2023-07-28 14:35
Empowering Regenerative Medicine: 3A-GTP Technology Ushers in a New Epoch 2023-07-28 10:00
HanAll Biopharma Reports Second Quarter 2023 Financial Results and Provides a Business Update 2023-07-27 19:00
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine 2023-07-27 14:00
GC Genome enables the prognosis prediction and targeted treatment in breast cancer patients 2023-07-27 08:53
1 68 69 70 71 72 431